Congenital cardiovascular malformations are the most common birth defect and contribute to the morbidity and mortality of our cardiovascular patients. The long range goal and the clinical significance of this proposal are to decipher the networks that govern the progenitors during endothelial development and regeneration. Our laboratory discovered Etv2/Etsrp71/ER71 as a transcriptional target of Nkx2-5 and demonstrated that Etv2 regulates the differentiation of endocardial/endothelial lineages. Additional studies further defined that Etv2 mutant embryos were nonviable and had perturbed mesodermal (endothelial, hematopoietic and cardiac) lineage development. Based on our novel results, our overall hypothesis is that Etv2 is an essential factor for the master molecular program for the endothelial lineage during development and regeneration. In these proposed studies, we will utilize a number of novel genetic models that we have engineered and take an innovative approach to dissect the role of Etv2 as a regulator of endothelial progenitors. To examine our hypotheses, we will address the following specific aims:
Specific Aim #1 : To define the regulation of the Etv2 gene during embryogenesis;
Specific Aim #2 : To define the functional role of microRNAs for the specification and differentiation of the endothelial lineage and Specific Aim #3: To define the cell fate of the Etv2 expressing cells during development and regeneration.
These aims will utilize our recently engineered genetic mouse models and ES cell lines to comprehensively define the role for Etv2 as an essential endothelial regulator and will serve as prelude for therapeutic initiatives to engineer and regenerate the vasculature. Given the tremendous morbidity and mortality of cardiovascular disease in our society, the potential impact of this proposal is significant.
Congenital vascular malformations are a common birth defect and contribute to the morbidity and mortality of our cardiovascular patients. The long range goal and the clinical significance of this proposal are to decipher the networks that govern the progenitors during endothelial development and regeneration. The results from these studies will serve as a prelude for therapeutic initiatives aimed at targeting the endothelial lineage during development, regeneration and disease.
|Gong, Wuming; Kwak, Il-Youp; Koyano-Nakagawa, Naoko et al. (2018) TCM visualizes trajectories and cell populations from single cell data. Nat Commun 9:2749|
|Gong, Wuming; Kwak, Il-Youp; Pota, Pruthvi et al. (2018) DrImpute: imputing dropout events in single cell RNA sequencing data. BMC Bioinformatics 19:220|
|Tahara, Naoyuki; Akiyama, Ryutaro; Theisen, Joshua W M et al. (2018) Gata6 restricts Isl1 to the posterior of nascent hindlimb buds through Isl1 cis-regulatory modules. Dev Biol 434:74-83|
|Koyano-Nakagawa, Naoko; Garry, Daniel J (2017) Etv2 as an essential regulator of mesodermal lineage development. Cardiovasc Res 113:1294-1306|
|Chen, Zhongming; Zhu, Wuqiang; Bender, Ingrid et al. (2017) Pathologic Stimulus Determines Lineage Commitment of Cardiac C-kit+ Cells. Circulation 136:2359-2372|
|Gong, Wuming; Rasmussen, Tara L; Singh, Bhairab N et al. (2017) Dpath software reveals hierarchical haemato-endothelial lineages of Etv2 progenitors based on single-cell transcriptome analysis. Nat Commun 8:14362|
|Garry, Daniel J (2016) Etv2 IS A MASTER REGULATOR OF HEMATOENDOTHELIAL LINEAGES. Trans Am Clin Climatol Assoc 127:212-223|
|Garry, Glynnis A; Antony, Marie Lue; Garry, Daniel J (2016) Cardiotoxin Induced Injury and Skeletal Muscle Regeneration. Methods Mol Biol 1460:61-71|
|Garry, Mary G; Garry, Daniel J (2015) Go to the Mattresses: A New Method for Human-Induced Pluripotent Stem Cell-Derived Cardiomyocyte Maturation. Circ Res 117:982-3|
|Doyle, Michelle J; Lohr, Jamie L; Chapman, Christopher S et al. (2015) Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease. Stem Cell Rev 11:710-27|
Showing the most recent 10 out of 19 publications